Elucent Medical wins FDA nod for EnVisio breast surgery navigation device
Elucent Medical said today that it won FDA 510(k) clearance for its EnVisio surgical navigation system.
The Eden Prairie, Minn.-based company said that the EnVisio navigation system is designed for use in conjunction with the company’s SmartClip soft tissue marker during breast cancer procedures.
The SmartClip soft tissue marker is an alternative to hook-wire localization procedures used to identify malignant tissue for removal, the company said. When used with the Envisio system allows physicians to mark difficult lesions and navigate distances, depths and directions in real-time 3D during breast cancer procedures.
...
Source: Mass Device - April 11, 2019 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Oncology Regulatory/Compliance Surgical Elucent Medical Source Type: news
Dune Medical launches first-in-man Smart Biopsy trial
Dune Medical Devices said today that it launched a first-in-man trial of its Smart Biopsy device, touting that the first patients in the trial have already been treated.
The first-in-man cases were performed by Dr. Noemi Weissenberg of Kfar Saba, Israel’s Meir Medical Center, the Alpharetta, Ga.-based company said.
Dune Medical’s Smart Biopsy system is a percutaneous soft tissue biopsy device that uses miniaturized sensors in the core needle to generate electrical parameters on sampled tissue in real-time. Those electrical signals are compared to histopahtologic findings to improve diagnosis and read-out.
̶...
Source: Mass Device - March 26, 2019 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Diagnostics Dune Medical Devices Inc. Source Type: news
New Technique Helps Women Protect Heart During Breast Cancer Treatment
CLEVELAND (CBS) — For women battling breast cancer, treatment can sometimes harm their hearts. Now a Cleveland hospital is using a technique to protect patients.
Joyce McCain’s breast cancer was picked up in a routine mammogram earlier this year. The 65-year-old considered her active lifestyle and decided a lumpectomy with radiation was the right treatment for her. Then doctors explained there could be side effects for the heart.
Joyce McCain (WBZ-TV)
“That gave me something else to start worrying about,” McCain said.
Joyce’s cancer was in her left breast, so radiation to treat the cancer could also expose he...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - December 25, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Breast Cancer Dr. Mallika Marshall Local TV Source Type: news
Accelerated PBI close but not equivalent to WBI to control ipsilateral breast tumor recurrence
(American Association for Cancer Research) Data from the NRG (NSABP B-39/RTOG 0413) trial indicated that ipsilateral breast tumor recurrence (IBTR) rates 10 years after treatment could not reject the hypothesis that accelerated partial breast irradiation (PBI) after lumpectomy was inferior to whole breast irradiation (WBI), according to a presentation at the 2018 San Antonio Breast Cancer Symposium. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 6, 2018 Category: International Medicine & Public Health Source Type: news
Meet the Post-Op Bra That & #039;s Long Overdue
Efrat Roman was diagnosed with breast cancer a little more than a decade ago and underwent a total of five different surgeries due to complications. As if going through multiple breast operations weren't challenging enough, Roman was surprised to find out that the post-op breast dressing options were severely lacking.
"I realized there wasn't anything designated for the dressing of breasts post-op," Roman told MD+DI. "There are reusable bras that are post-op bras, but the fact that they are reusable is not enough because many breast cancer patients will suffer from some kind of asymmetry and with the reusable bras there is...
Source: MDDI - November 30, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news
EZbra: Why Didn & #039;t Anyone Think of This Before?
Efrat Roman was diagnosed with breast cancer a little more than a decade ago and underwent a total of five different surgeries due to complications. As if going through multiple breast operations weren't challenging enough, Roman was surprised to find out that the post-op breast dressing options were severely lacking.
"I realized there wasn't anything designated for the dressing of breasts post-op," Roman told MD+DI. "There are reusable bras that are post-op bras, but the fact that they are reusable is not enough because many breast cancer patients will suffer from some kind of asymmetry and with the reusable bras there is...
Source: MDDI - November 30, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news
Cryoablation a Promising Alternative to Surgery in Low-Risk Breast Cancer Cryoablation a Promising Alternative to Surgery in Low-Risk Breast Cancer
Image-guided cryoablation can be an effective primary treatment for small, low-risk breast tumors without lumpectomy, according to new data from the ongoing Ice 3 trial.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 29, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Image-Guided Cryoablation: an Option in Early Breast Cancer?
(MedPage Today) -- Researchers tout as potential alternative to lumpectomy in low-risk disease (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - November 29, 2018 Category: Hematology Source Type: news
Merit Medical closes $200m Cianna Medical buy
Merit Medical (NSDQ:MMSI) said yesterday that it closed its $200 million acquisition of Cianna Medical, making the company a wholly-owned subsidiary.
Aliso Viejo, Calif.-based Cianna makes the Savi Scout wire-free breast tumor localization system, designed to produce audible and visual indicators surgeons can use to tag cancerous tissue during lumpectomy and biopsy procedures. The device won 510(k) clearance from the FDA in December 2014.
The deal included an up-front cash payment of $135 million, plus $15 million in earn-outs pegged to supply chain and scalability goals and another $50 million in sales milestones, So...
Source: Mass Device - November 14, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured Mergers & Acquisitions Women's Health Cianna Medical Merit Medical Systems Inc. Source Type: news
Texas woman livestreams breast cancer surgery to 26,000 Facebook users
Sonia Johnson of Texas was diagnosed with breast cancer last December. In honor of breast cancer awareness month and in the hopes others will get checked, she streamed her lumpectomy today. (Source: the Mail online | Health)
Source: the Mail online | Health - October 25, 2018 Category: Consumer Health News Source Type: news
Researchers Want Cancer Patients To Share Their Medical Information In Search of Cures
April Doyle, a single mom from Visalia, Cal., only lets herself look three months into her future. Since she was first diagnosed with breast cancer in 2014, she’s tried a new treatment every three months to keep the cancer from spreading from her breast tissue to other parts of her body. But it returned: this time in her bone. She is almost out of options for her hard-to-treat cancer, but she finds comfort in online support groups where other women with metastatic breast cancer share their experiences. “Eventually we know we will exhaust all of our options until they keep coming up with more treatments,” ...
Source: TIME: Health - October 18, 2018 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Cancer healthytime Source Type: news
Lumpectomy + Radiation May Cut Breast Cancer Mortality in DCIS
Lumpectomy, radiotherapy tied to reduction in breast cancer mortality versus lumpectomy, mastectomy (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - August 20, 2018 Category: Cancer & Oncology Tags: Gynecology, Oncology, Radiology, Surgery, Journal, Source Type: news
Lumpectomy & #43; Radiation May Cut Breast Cancer Mortality in DCIS
MONDAY, Aug. 20, 2018 -- Treatment with lumpectomy and radiotherapy is associated with a reduction in breast cancer mortality versus lumpectomy or mastectomy alone among patients with ductal carcinoma in situ (DCIS), according to a study published... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 20, 2018 Category: Pharmaceuticals Source Type: news
Is radiation therapy warranted for DCIS postlumpectomy?
Researchers have found that radiation therapy after lumpectomy in women with...Read more on AuntMinnie.comRelated Reading:
Microbubbles improve breast cancer radiation therapy
ASTRO: Short radiation course safe for breast cancer
LED device could predict skin damage from breast RT
Robotic IMRT-APBI works well for breast cancer patients
SABCS: Study links APBI to higher complication rates (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 10, 2018 Category: Radiology Source Type: news
Lumpectomy Plus RT Tied to Lower Mortality in DCIS Lumpectomy Plus RT Tied to Lower Mortality in DCIS
Lumpectomy plus radiation is associated with a small but statistically significant reduced risk for breast cancer-related death compared to the other major options for ductal carcinoma in situ (DCIS).Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 10, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
